Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Case report

Systemic administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against metastatic melanoma

Med Sci Monit 2003; 9(1): 69-0 :: ID: 15212

Metrics

Views & Downloads

Views: 806

Downloads: 0
Maximum downloads: 0 (